Tandem Diabetes Care (TNDM) Capital Expenditures Growth (5y) (2018 - 2026)
Powered by 
Analysis
Tandem Diabetes Care (TNDM) Capital Expenditures Growth (5y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.78 Bn | 175.17 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.04 Bn | 121.82 Bn | 1.96 Bn |
| 3 | Medtronic | 117.04 Bn | 108.22 Bn | 6.34 Bn |
| 4 | Stryker | 103.86 Bn | 100.38 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.50 Bn | 62.96 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn |
| 8 | Dexcom | 32.12 Bn | 30.17 Bn | 830.00 Mn |
| 9 | Steris | 20.69 Bn | 20.21 Bn | 684.20 Mn |
| 10 | Tandem Diabetes Care | 1.27 Bn | 811.05 Mn | 144.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.56% |
| Mar 31, 2026 | 19.31% |
| Dec 31, 2025 | 10.29% |
| Sep 30, 2025 | -9.55% |
| Jun 30, 2025 | -12.65% |
| Mar 31, 2025 | -9.12% |
| Dec 31, 2024 | -14.58% |
| Sep 30, 2024 | 2.53% |
| Jun 30, 2024 | -0.89% |
| Mar 31, 2024 | 25.92% |
| Dec 31, 2023 | 42.40% |
| Sep 30, 2023 | 39.81% |
| Jun 30, 2023 | 66.70% |
| Mar 31, 2023 | 76.60% |
| Dec 31, 2022 | 31.72% |
| Sep 30, 2022 | 123.84% |
| Jun 30, 2022 | 53.71% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 15.94% |
| Sep 30, 2021 | 7.67% |